Beactica Therapeutics to present update on LSD1 programme at

/PRNewswire/ -- Beactica Therapeutics AB, the Swedish precision oncology company, today announced that its LSD1 programme has been selected for a poster...

Related Keywords

Orlando , Florida , United States , Orange County Convention Center , Sweden , Stockholm , Swedish , American , Konrad Koehler , Drug Administration , American Association For Cancer Research Annual Meeting , American Association For Cancer Research , American Association , Cancer Research , Annual Meeting , Sunday April , Abstract Presentation Number , Orphan Drug Designation , Beactica Therapeutics Ab ,